Apparatus and method for deployment of a therapeutic device using a catheter

Information

  • Patent Grant
  • 8652163
  • Patent Number
    8,652,163
  • Date Filed
    Friday, September 28, 2012
    12 years ago
  • Date Issued
    Tuesday, February 18, 2014
    10 years ago
Abstract
The apparatus for deployment of an intravascular therapeutic device, includes an elongated, flexible pusher member and a therapeutic device connected to a severable portion of a first connector member mounted to the flexible pusher member with an elongated second connector member connected to the therapeutic device. The first connector member or second connector member may be capable of being broken by heat, and a heat source is provided for heating and breaking the first connector member or the second connector member to release the therapeutic device.
Description
FIELD OF THE INVENTION

This invention relates generally to devices for intravascular interventional therapeutic treatment or vascular surgery for treatment of defects in the vasculature, and more particularly concerns a system and method for delivering intravascular interventional devices, such as for treatment of aneurysms.


BACKGROUND OF THE INVENTION

Vascular interventional devices such as vasoocclusive devices are typically placed within the vasculature of the human body by use of a catheter. Vascular interventional devices such as stents can be placed within an occluded vessel to facilitate blood flow through the vessel, and vasoocclusive devices are typically either placed within a blood vessel to block the flow of blood through the vessel by forming an embolus, or are placed within an aneurysm stemming from the vessel to form an embolus within the aneurysm. Stents can have a wide variety of configurations, but generally need to be placed and then released at a desired location within a blood vessel. Vasoocclusive devices used for these procedures can also have a wide variety of configurations, and aneurysms have been treated with external surgically placed clips, detachable vasoocclusive balloons and embolus generating vasoocclusive devices such as one or more vasoocclusive coils.


The delivery of such vasoocclusive devices have typically been accomplished by a variety of means, including via a catheter in which the device is pushed through an opening at the distal end of the catheter by a pusher to deploy the device. The vasoocclusive devices can be produced in such a way that they will pass through the lumen of a catheter in a linear shape and take on a complex shape as originally formed after being deployed into the area to be treated, such as an aneurysm.


One conventional releasable balloon catheter used to embolize vascular lesions has a tube portion made of a material such as a hydrophilic polymer, located between the catheter and the balloon, that can be melted by heating the tube, or can be dissolved in the blood when heated, and electrodes are provided for heating the tube. Another conventional technique for separating a balloon from a balloon catheter involves the melting and breaking of a connecting member between the balloon and the catheter body, when power is supplied to electrodes provided for heating the connecting member. When the connecting member is heated to temperatures of about 70° C. and slight tension is applied, the balloon can be separated from the main catheter body.


An implant delivery assembly is also known that is used for delivery of implants such as embolic coils, utilizing a shape memory decoupling mechanism activated when exposed to body temperature. A cooling solution is flushed through the catheter during introduction and placement of the implant in order to prevent premature release of the implant prior to the time that the implant is to be released. Another implant delivery assembly includes an electrical heating system for heating the coupling mechanism to a temperature at which the shape memory material returns to its original shape, to deploy the implant.


Another device is known in which a device to be implanted is detached by application of a high-frequency current which melts and severs a resin that is used to retain the device to be implanted until the device is to be deployed. In another known device, an electrolytically severable link is dissolved by activation of a power source electrically coupled to the electrolytically severable link to detach the device to be implanted.


In another conventional technique, a conductive guidewire delivers a high frequency current through the guidewire to melt and sever a joint to detach an implanted device from the guidewire. The patient is grounded during the procedure, and current is introduced via the guidewire, rather than with a two way current path.


Such devices that release the interventional device by melting or dissolving the intermediate section between the catheter tip and implanted device may cause thermal damage of surrounding tissues during detachment that can cause embolization in the bloodstream, and may also potentially release undesirable particles of materials into the bloodstream that can also cause embolization in the bloodstream. There is therefore a need for a precise method of deploying therapeutic interventional devices without compromising the position of the implant, without causing thermal damage to surrounding tissues, and without releasing undesirable particles of materials into the bloodstream and risking the formation of emboli in the bloodstream. The present invention meets these and other needs.


SUMMARY OF THE INVENTION

Briefly, and in general terms, the present invention provides for an apparatus for deployment of an intravascular therapeutic device, such as a vasoocclusive device, a microcoil, at least one electrode, a stent, or a coated coil, for example, using an elongated, flexible pusher member. The therapeutic device is connected to a first connector member mounted to the flexible pusher member with an elongated second connector member connected between the first connector member and the therapeutic device. At least one of the first and second connector members includes a severable portion that is capable of being severed, such as by melting or degradation, by heat. A heat source is provided for heating and breaking the severable portion of the first or second connector member to release the therapeutic device. The first connector member may be formed from a molded thermoplastic material, such as high density polyethylene, and the elongated second connector member may be a connector fiber, or a ribbon, for example. The elongated second connector member may also be formed from a thermoplastic material, such as high density polyethylene. The heat source is advantageously contained substantially within the pusher member, which provides a sufficient amount of thermal insulation to eliminate the potential for thermal damage to surrounding tissues during detachment of the therapeutic device. Since the severable first connecting member is heated and broken at a location fully contained within the pusher member, the potential for releasing undesirable particles of materials into the bloodstream and consequent embolization in the bloodstream is virtually eliminated.


The invention accordingly provides for an apparatus for release and deployment of a therapeutic device within the vasculature of a patient, the apparatus including an elongated, flexible pusher member having an interior lumen, a first connector member mounted to the elongated, flexible pusher member. In one aspect, the first connector member may have a severable portion capable of being broken by heating disposed within the elongated, flexible pusher member. An elongated second connector member is connected to the therapeutic device and detachably connected to the first connector member. The elongated second connector member thereby connects the therapeutic device to the pusher member for placement of the therapeutic device within the vasculature, and in one aspect, the elongated second connector member may have a severable portion capable of being broken by heating disposed within the elongated, flexible pusher member.


In one aspect, a heat source may be disposed in the interior lumen of the pusher member adjacent to the first connector member for heating the severable portion of the first connector member to cause the severable portion of the first connector member to break and release the elongated second connector member for detaching and deploying the therapeutic device from the flexible pusher member when a desired placement of the therapeutic device within the vasculature is achieved.


In another aspect, the first connector member may be formed from a molded thermoplastic, such as high density polyethylene, for example. The first connector member may be molded in the form of a rod extending across the interior diameter of the interior lumen of the pusher member, a post, a ring, or other similar suitable configurations. In another aspect, the heat source may include an electrical resistance heat source coil. Alternatively, the heat source may include an induction ring, and may be included in the first connector member, for severing the elongated second connector member. A control unit is typically connected to the heat source to supply electrical current to the heat source. The flexible pusher member typically includes a heat insulating shaft having an entry port communicating with the interior lumen of the pusher member, and the heat source is disposed in the interior lumen of the pusher member adjacent to the entry port. The flexible pusher member has a distal tip, and in one aspect, the heat source may be spaced apart from the distal tip of the flexible pusher member.


In other aspects, the elongated second connector member may be a connector fiber, or may be a ribbon. The therapeutic device may be a vasoocclusive device, a microcoil, at least one electrode, a stent, or a coated coil, for example.


These and other aspects and advantages of the invention will become apparent from the following detailed description and the accompanying drawings, which illustrate by way of example the features of the invention.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a top sectional view of a first embodiment of the apparatus for release and deployment of a therapeutic device.



FIG. 2 is a side sectional view of the apparatus of FIG. 1.



FIG. 3 is a top sectional view of a second embodiment of the apparatus for release and deployment of a therapeutic device.



FIG. 4 is a top sectional view of a third embodiment of the apparatus for release and deployment of a therapeutic device.



FIG. 5 is a side sectional view of the apparatus of FIG. 1, illustrating release of the therapeutic device.



FIG. 6 is a side sectional view of the apparatus of FIG. 3, illustrating release of the therapeutic device.



FIG. 7 is a side sectional view of the apparatus of FIG. 4, illustrating release of the therapeutic device.



FIG. 8 is a top sectional view of a fourth embodiment of the apparatus for release and deployment of a therapeutic device.



FIG. 9 is a side sectional view of the apparatus of FIG. 8.



FIG. 10 is a side sectional view of the apparatus of FIG. 8, illustrating release of the therapeutic device.





DETAILED DESCRIPTION OF THE INVENTION

While vasoocclusive devices have conventionally been delivered to a portion of a patient's vasculature to be treated through a delivery catheter by means of a pusher device, such conventional methods can involve separation of the vasoocclusive device from the pusher device in ways that result in injury to the vasculature, such as by causing thermal damage of surrounding tissues during detachment that can cause embolization in the bloodstream, or by release of undesirable particles of materials into the bloodstream that can cause embolization in the bloodstream.


With reference to FIGS. 1-10, the invention provides for an apparatus 40 including an elongated, flexible pusher member 42 for release and deployment of a therapeutic device 44 such as a vasoocclusive device, which may for example be a microcoil, only a portion of which is shown, within the vasculature of a patient, through a delivery catheter 46. The therapeutic device may alternatively be one or more electrodes, a stent, a coated coil, or the like, for example. The pusher member has a shaft 47 that provides a measure of thermal insulation to an interior lumen 48, as will be further explained below. The shaft of the pusher member typically has an outer diameter of approximately 0.015″, and an inside diameter of approximately 0.007, and can be formed from polyethylene terephthalate (PET) tubing.


In a first embodiment illustrated in FIGS. 1, 2 and 5, the pusher member has a portion 50 with an entry port 52 in communication with the interior lumen, and a plug 54 at the distal end 56 of the pusher member, typically secured within the distal end of the pusher member by adhesive, such as a cyanoacrylate adhesive, for example.


A first connector member 58 is mounted to the elongated, flexible pusher member, and has a severable portion 60 disposed within the elongated, flexible pusher member that is capable of being broken by heating. The first connector member is typically formed from a molded thermoplastic material, such as high density polyethylene. In the first embodiment, the first connector member may be molded in the form of a rod 61 extending across and connected between opposing sides of the interior diameter of the interior lumen of the pusher member, as is shown in FIGS. 1 and 2.


In a second embodiment illustrated in FIGS. 3 and 6, in which the same elements from the first embodiment are shown with the same reference numbers, the first connector member may have the configuration of a post 62 connected at one end to the pusher member and having a free end with an enlarged portion 63 larger than the entry port, and having a severable portion 64 that is capable of being broken by heating, typically formed from a molded thermoplastic material, such as high density polyethylene, as is shown in FIG. 3.


In a third embodiment illustrated in FIGS. 4 and 7, in which the same elements from the first embodiment are shown with the same reference numbers, the first connector member may have the configuration of a ring 65 connected to the pusher member and having a severable portion 67, that is capable of being broken by heating, typically formed from a molded thermoplastic material, such as high density polyethylene, as is shown in FIG. 4, for example.


In each embodiment, the therapeutic device includes an elongated second connector member 66 connected to the therapeutic device, such as by being looped through an end coil 68 of a microcoil therapeutic device, for example. The elongated second connector member may alternatively be tied or bonded to the therapeutic device, such as by heat bonding, or by an adhesive such as a cyanoacrylate adhesive, for example. The elongated second connector member is typically looped around the first connector member when the first connector member is a rod or post, or through the first connector member, when the first connector member is a ring. The elongated second connector member may be a connector fiber, or a ribbon, that may be made of polyethylene, or another suitable fiber material, for example. In a presently preferred embodiment, the elongated second connector member is formed of polyethylene, and is typically about 0.015 to 0.030 inches in diameter, although the elongated second connector member can be as thin as about 0.0005 inches in diameter, and can be formed from a variety of thermoplastic materials with high tensile strength. The elongated second connector member may also optionally be formed of a suitable high tensile strength material, for example.


In the foregoing embodiments, a heat source such as a resistive heat source coil 70 is disposed in the interior lumen of the pusher member adjacent to the severable portion of the first connector member for heating the severable portion of the first connector member to cause the severable portion of the first connector member to break and release the elongated second connector member, to thereby detach and deploy the therapeutic device from the flexible pusher member when a desired placement of the therapeutic device within the vasculature is achieved. The heat source may be spaced apart from the distal end of the pusher member. The heat source is connected by electrical connectors 72 to a control unit 74 which supplies electrical current to the resistive heat source coil to cause the severable connector member to break and release the therapeutic device. Alternatively, the heat source may deliver heat to the severable connector member by other means, such as thermo-mechanical, electromagnetic or RF energy, for example. The lumen of the pusher member advantageously provides an insulative space and wall thickness to contain the heating of the severable connector member to avoid thermal damage to surrounding tissues, and to help contain pieces of the severable connector member that may be formed during heating of the severable connector member to deploy the therapeutic device. The therapeutic device is thus detachably connected to the first connector member by the elongated second connector member, for placement of the therapeutic device within the vasculature.


In a fourth embodiment illustrated in FIGS. 8-10, in which the same elements from the first embodiment are shown with the same reference numbers, the first connector member has the form of a ring 76 mounted to the elongated, flexible pusher member. In the fourth embodiment, the first connector member is preferably an induction ring providing a heat source disposed in the interior lumen of the pusher member, and having a narrow, thin edge portion or blade 78, that can be heated. The blade is positioned to be in contact with the elongated second connector member 66, such as a fiber or ribbon that will melt when heated sufficiently, as explained above. The second connector member is connected to the therapeutic device, so that when the blade of the induction ring is heated, such as by electrical current from electrical connectors 72 connected to a control unit 74, as explained above, the first connector member will sever the second connector member, to release the therapeutic device.


It will be apparent from the foregoing that while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.

Claims
  • 1. An apparatus for release and deployment of a therapeutic device within the vasculature of a patient, comprising: an elongated, flexible pusher member having an interior lumen;a first connector member mounted to said elongated, flexible pusher member, said first connector member including an induction ring disposed in the interior lumen of the pusher member, said induction ring having an edge portion configured to be heated;an elongated second connector member connected to a therapeutic device and detachably connected to the first connector member, said elongated second connector member thereby connecting the therapeutic device to the pusher member for placement of the therapeutic device within the vasculature, said second connector member having a severable portion configured to be broken by heating disposed within said elongated, flexible pusher member, said severable portion of said second connector member being positioned in contact with said edge portion of said induction ring for heating said severable portion of said second connector member to cause said severable portion of said second connector member to break and release the elongated second connector member for detaching and deploying the therapeutic device from the flexible pusher member when a desired placement of the therapeutic device within the vasculature is achieved.
  • 2. The apparatus of claim 1, further comprising a control unit, and wherein said induction ring is connected by electrical connectors to the control unit which supplies electrical current to the induction ring.
  • 3. The apparatus of claim 1, wherein said flexible pusher member comprises a heat insulating shaft.
  • 4. The apparatus of claim 1, wherein said pusher member includes an entry port communicating with said interior lumen of said pusher member, and said induction ring is disposed in the interior lumen of the pusher member adjacent to said entry port.
  • 5. The apparatus of claim 1, wherein said elongated second connector member is a connector fiber.
  • 6. The apparatus of claim 1, wherein said elongated second connector member comprises a ribbon.
  • 7. The apparatus of claim 1, wherein said flexible pusher member has a distal tip, and the induction ring is spaced apart from said distal tip of said flexible pusher member.
  • 8. The apparatus of claim 1, wherein said therapeutic device is a vasoocclusive device.
  • 9. The apparatus of claim 1, wherein said therapeutic device comprises a microcoil.
CROSS REFERENCES TO RELATED APPLICATIONS

This is a continuation of application Ser. No. 12/814,397 filed 11 Jun. 2010, now U.S. Pat. No. 8,298,256, which is a continuation of application Ser. No. 11/726,074 filed 21 Mar. 2007, now U.S. Pat. No. 7,740,637, which is a continuation-in-part of application Ser. No. 11/020,936, filed 22 Dec. 2004, now U.S. Pat. No. 7,198,613, which is a continuation of application Ser. No. 10/290,777, filed 7 Nov. 2002, now U.S. Pat. No. 6,966,892, which is a continuation of application Ser. No. 09/501,466, filed 9 Feb. 2000, now U.S. Pat. No. 6,478,773.

US Referenced Citations (219)
Number Name Date Kind
1341052 Gale May 1920 A
2078182 MacFarland Apr 1937 A
2549335 Rahthus Apr 1951 A
3334629 Cohn Aug 1967 A
3485234 Stevens Dec 1969 A
3649224 Anderson et al. Mar 1972 A
3868956 Alfidi et al. Mar 1975 A
4327734 White, Jr. May 1982 A
4341218 U Jul 1982 A
4346712 Handa et al. Aug 1982 A
4402319 Handa et al. Sep 1983 A
4441495 Hicswa Apr 1984 A
4494531 Gianturco Jan 1985 A
4512338 Balko et al. Apr 1985 A
4545367 Tucci Oct 1985 A
4553545 Maass et al. Nov 1985 A
4611594 Grayhack et al. Sep 1986 A
4629458 Pinchuk Dec 1986 A
4638803 Rand Jan 1987 A
RE32348 Pevsner Feb 1987 E
4655771 Wallsten Apr 1987 A
4662068 Polonsky May 1987 A
4670286 Nyilas et al. Jun 1987 A
4718907 Karwoski et al. Jan 1988 A
4732152 Wallsten et al. Mar 1988 A
4748986 Morrison et al. Jun 1988 A
4768507 Fischell et al. Sep 1988 A
4795458 Regan Jan 1989 A
4798606 Pinchuk Jan 1989 A
4800882 Gianturco Jan 1989 A
4813925 Anderson, Jr. et al. Mar 1989 A
4820298 Leveen et al. Apr 1989 A
4830003 Wolff et al. May 1989 A
4850960 Grayzel Jul 1989 A
4856516 Hillstead Aug 1989 A
4873978 Ginsburg Oct 1989 A
4944746 Iwata et al. Jul 1990 A
4950258 Kawai et al. Aug 1990 A
4954126 Wallsten Sep 1990 A
4957479 Roemer Sep 1990 A
4957501 Lahille et al. Sep 1990 A
4969890 Sugita et al. Nov 1990 A
4990155 Wilkoff Feb 1991 A
4994069 Ritchart et al. Feb 1991 A
4994071 MacGregor Feb 1991 A
5002556 Ishida et al. Mar 1991 A
5015253 MacGregor May 1991 A
5019090 Pinchuk May 1991 A
5026377 Burton et al. Jun 1991 A
5035706 Giantureo et al. Jul 1991 A
5037377 Alonso Aug 1991 A
5041084 DeVries et al. Aug 1991 A
5041126 Gianturco Aug 1991 A
5061275 Wallsten et al. Oct 1991 A
5064435 Porter Nov 1991 A
5071407 Termin et al. Dec 1991 A
5101094 Keller et al. Mar 1992 A
5104404 Wolff Apr 1992 A
5108407 Geremia et al. Apr 1992 A
5109867 Twyford, Jr. May 1992 A
5122136 Guglielmi et al. Jun 1992 A
5122137 Lennox Jun 1992 A
5133364 Palermo et al. Jul 1992 A
5133731 Butler et al. Jul 1992 A
5133732 Wiktor Jul 1992 A
5141502 Macaluso, Jr. Aug 1992 A
5143085 Wilson Sep 1992 A
5147370 McNamara et al. Sep 1992 A
5151105 Kwan-Gett Sep 1992 A
5152784 Tsilibary Oct 1992 A
5160341 Brenneman et al. Nov 1992 A
5171273 Silver et al. Dec 1992 A
5176625 Brisson Jan 1993 A
5176661 Evard et al. Jan 1993 A
5181921 Makita et al. Jan 1993 A
5183085 Timmermans Feb 1993 A
5186992 Kite, III Feb 1993 A
5188621 Samson Feb 1993 A
5192290 Hilal Mar 1993 A
5197977 Hoffman, Jr. et al. Mar 1993 A
5203772 Hammerslag et al. Apr 1993 A
5211658 Clouse May 1993 A
5217484 Marks Jun 1993 A
5222969 Gillis Jun 1993 A
5222970 Reeves Jun 1993 A
5224953 Morgentaler Jul 1993 A
5226911 Chee et al. Jul 1993 A
5226913 Pinchuk Jul 1993 A
5228453 Sepetka Jul 1993 A
5234437 Sepetka Aug 1993 A
5234456 Silvestrini Aug 1993 A
5238004 Sahatjian et al. Aug 1993 A
5250071 Palermo Oct 1993 A
5256146 Ensminger et al. Oct 1993 A
5258042 Mehta Nov 1993 A
5261916 Engelson Nov 1993 A
5275173 Samson et al. Jan 1994 A
5304194 Chee et al. Apr 1994 A
5304198 Samson Apr 1994 A
5312415 Palermo May 1994 A
5314472 Fontaine May 1994 A
5322501 Mahmud-Durrani Jun 1994 A
5334217 Das Aug 1994 A
5336205 Zenzen et al. Aug 1994 A
5341818 Abrams et al. Aug 1994 A
5342387 Summers Aug 1994 A
5350397 Palermo et al. Sep 1994 A
5354295 Guglielmi et al. Oct 1994 A
5354309 Schnepp-Pesch et al. Oct 1994 A
5368049 Raman et al. Nov 1994 A
5373856 Grenouillet Dec 1994 A
5382259 Phelps et al. Jan 1995 A
5383887 Nadal Jan 1995 A
5395390 Simon et al. Mar 1995 A
5405377 Cragg Apr 1995 A
5409015 Palermo Apr 1995 A
5411475 Atala et al. May 1995 A
5413597 Krajicek May 1995 A
5415664 Pinchuk May 1995 A
5417708 Hall et al. May 1995 A
5423829 Pham et al. Jun 1995 A
5433723 Lindenberg et al. Jul 1995 A
5441516 Wang et al. Aug 1995 A
5443478 Purdy Aug 1995 A
5443498 Fontaine Aug 1995 A
5484449 Amundson et al. Jan 1996 A
5500013 Buscemi et al. Mar 1996 A
5514115 Frantzen et al. May 1996 A
5514176 Bosley, Jr. May 1996 A
5520194 Miyata et al. May 1996 A
5522822 Phelps et al. Jun 1996 A
5522836 Palermo Jun 1996 A
5523092 Hanson et al. Jun 1996 A
5527336 Rosenbluth et al. Jun 1996 A
5540701 Sharkey et al. Jul 1996 A
5549624 Mirigian et al. Aug 1996 A
5562641 Flomenblit et al. Oct 1996 A
5562698 Parker Oct 1996 A
5569245 Guglielmi et al. Oct 1996 A
5578074 Mirigian Nov 1996 A
5582619 Ken Dec 1996 A
5603694 Brown et al. Feb 1997 A
5607445 Summers Mar 1997 A
5609627 Goicoechea et al. Mar 1997 A
5613981 Boyle et al. Mar 1997 A
5624461 Mariant Apr 1997 A
5637113 Tartaglia et al. Jun 1997 A
5638827 Palmer et al. Jun 1997 A
5639277 Mariant et al. Jun 1997 A
5643254 Scheldrup et al. Jul 1997 A
5643339 Kavteladze et al. Jul 1997 A
5645564 Northrup et al. Jul 1997 A
5649949 Wallace et al. Jul 1997 A
5653726 Kieturakis Aug 1997 A
5653727 Wiktor Aug 1997 A
5666968 Imran et al. Sep 1997 A
5667522 Flomenblit et al. Sep 1997 A
5676697 McDonald Oct 1997 A
5690643 Wijay Nov 1997 A
5690666 Berenstein et al. Nov 1997 A
5690671 McGurk et al. Nov 1997 A
5693085 Buirge et al. Dec 1997 A
5702373 Samson Dec 1997 A
5702414 Richter et al. Dec 1997 A
5713907 Hogendijk et al. Feb 1998 A
5722989 Fitch et al. Mar 1998 A
5725546 Samson Mar 1998 A
5733329 Wallace et al. Mar 1998 A
5743905 Eder et al. Apr 1998 A
5746765 Kleshinski et al. May 1998 A
5746769 Ton et al. May 1998 A
5749883 Halpern May 1998 A
5749891 Ken et al. May 1998 A
5749894 Engelson May 1998 A
5749918 Hogendijk et al. May 1998 A
5749921 Lenker et al. May 1998 A
5759161 Ogawa et al. Jun 1998 A
5788653 Lorenzo Aug 1998 A
5797957 Palmer et al. Aug 1998 A
5800455 Palermo Sep 1998 A
5800526 Anderson et al. Sep 1998 A
5814062 Sepetka et al. Sep 1998 A
5824059 Wijay Oct 1998 A
5911737 Lee et al. Jun 1999 A
5944733 Engelson Aug 1999 A
5947963 Guglielmi Sep 1999 A
5964771 Beyar et al. Oct 1999 A
5984929 Bashiri et al. Nov 1999 A
5989242 Saadat et al. Nov 1999 A
6059815 Lee et al. May 2000 A
6102933 Lee et al. Aug 2000 A
6139520 McCrory et al. Oct 2000 A
6159165 Ferrera et al. Dec 2000 A
6168570 Ferrera Jan 2001 B1
6224610 Ferrera May 2001 B1
6270495 Palermo Aug 2001 B1
6296622 Debeer et al. Oct 2001 B1
6338736 Boosfeld et al. Jan 2002 B1
6478773 Gandhi et al. Nov 2002 B1
6500149 Gandhi et al. Dec 2002 B2
6616617 Ferrera et al. Sep 2003 B1
6656173 Palermo Dec 2003 B1
6835185 Ramzipoor et al. Dec 2004 B2
6966892 Gandhi et al. Nov 2005 B2
7198613 Gandhi et al. Apr 2007 B2
7422569 Wilson et al. Sep 2008 B2
7575582 Gandhi et al. Aug 2009 B2
7578826 Gandhi et al. Aug 2009 B2
7740637 Gandhi et al. Jun 2010 B2
7776054 Gandhi et al. Aug 2010 B2
7780680 Gandhi et al. Aug 2010 B2
20010029352 Gandhi et al. Oct 2001 A1
20020138025 Gellman et al. Sep 2002 A1
20050043755 Wilson et al. Feb 2005 A1
20060020333 Lashinski et al. Jan 2006 A1
20060025801 Lulo et al. Feb 2006 A1
20060265001 Marks Nov 2006 A1
20070060938 Dziadik et al. Mar 2007 A1
20070167911 Gandhi et al. Jul 2007 A1
Foreign Referenced Citations (33)
Number Date Country
4102550 Aug 1981 DE
19704269 Nov 1997 DE
183372 Jun 1986 EP
278937 Aug 1988 EP
382014 Aug 1990 EP
518704 Dec 1992 EP
627201 Dec 1994 EP
717961 Dec 1995 EP
592182 Jul 1925 FR
2066839 Jul 1981 GB
998981 May 1980 JP
6030225 Apr 1981 JP
6420841 Jan 1989 JP
64020841 Jan 1989 JP
2255157 Oct 1990 JP
5501022 Feb 1993 JP
7265431 Oct 1995 JP
11197250 Jul 1999 JP
9105300 Apr 1991 WO
9214408 Sep 1992 WO
9416629 Aug 1994 WO
9518585 Jul 1995 WO
9521592 Aug 1995 WO
9701368 Jan 1997 WO
9730642 Aug 1997 WO
9748351 Dec 1997 WO
9822042 May 1998 WO
9822175 May 1998 WO
9837816 Sep 1998 WO
9929260 Jun 1999 WO
0158366 Aug 2001 WO
2005032337 Apr 2005 WO
2006076537 Jul 2006 WO
Non-Patent Literature Citations (19)
Entry
JPO, Final Notification of Reasons for Rejection in Japanese Patent Application No. 2001-557480 (translation), Dispatched Sep. 19, 2010, Japan Patent Office, Tokyo, Japan.
Athanasoulis, Christos A., M.D., “Therapeutic Applications of Angiography”, The New England Journal of Medicine, May 15, 1980, pp. 1117-1125 (1 of 2).
Athanasoulis, Christos A., M.D., “Therapeutic Applications of Angiography”, The New England Journal of Medicine, May 22, 1980, pp. 1174-1179 (2 of 2).
Berenstein, Alex, M.D. et al., “Catheter and Material Selection for Transarterial Embolization: Technical Considerations” Radiology, Sep. 1979; pp. 631-639.
Battista, O.A. et al.. “Colloidal Macromolecular Phenomena. Part II. Novel Microcrystals of Polymers”, Journal of Applied Polymer Science 1967, pp. 481-498.
Hilal, Sadek K., M.D. et al. “Therapeutic Percutaneous Embolization for Extra-Axial Vascular Lesions of the Head, Neck and Spine”, Journal of Neurological Surgery, Sep. 1975; pp. 275-287.
Kaufman, Stephen L., M.D. et al., “Transcatheter Embolization with Microfibrillar Collagen in Swine”, Investigative Radiology, May-Jun. 1978, pp. 200-204.
Kumar, Ashok J. et al., “Preoperative Embolization of Hypervascular Head and Neck Neoplasms Using Microfibrillar Collagen”, Journal of Neuroradiology (1982), pp. 163-168.
Latchaw, Richard E., M.D. et al., “Polyvinyl Foam Embolization of Vascular and Neoplastic Lesions of the Head, Neck and Spine”, Radiology (1979), pp. 669-679.
Reuter, Stewart R., M.D. et al., “Selective Arterial Embolization for Control of Massive Upper Gastrointestinal Bleeding”, American Journal of Radiology, Sep. 1975, pp. 119-126.
Roberson, Glenn H. et al., “Therapeutic Embolization of Juvenile Angiofibroma”, American Journal of Radiology, Oct. 1979, pp. 657-663.
Gianturco, C., M.D. et al. “Mechanical Devices for Arterial Occlusion”, Am. J Roentgenol Jul. 1975, pp. 428-435.
Wallace, Sidney, M.D. et al., “Therapeutic Vascular Occlusion Utilizing Steel Coil Technique: Clinical Applications”, Am. J Roentgenol (1976); pp. 381-387.
Anderson, James H. et al., “Transcatheter Intravascular Coil Occlusion of Experimental Arteriovenous Fistulas”, Am. J. Roentgenol, Nov. 1977, pp. 795-798.
Anderson, James H. et al., “‘Mini’ Gianturco Stainless Steel Coils for Transcatheter Vascular Occlusion”, Radiology, Aug. 1978, pp. 301-303.
Chuang, Vincent P., M.D., et al., “A New Improved Coil for Tapered-Tip Catheter for Arterial Occlusion” by May 1980, pp. 507-509.
Hawkins, Jeffrey, M.D. et al., “Retrievable Gianturco-Coil Introducer”, Radiology, Jan. 1986, 262-264.
Wallace, Sidney, M.D. et al., “Arterial Occlusion of Pelvic Bone Tumors”, Cancer, Oct. 1979, pp. 322-325 & 661-663.
International Search Report, May 3, 2001, 6 pages.
Related Publications (1)
Number Date Country
20130023922 A1 Jan 2013 US
Continuations (4)
Number Date Country
Parent 12814397 Jun 2010 US
Child 13630800 US
Parent 11726074 Mar 2007 US
Child 12814397 US
Parent 10290777 Nov 2002 US
Child 11020936 US
Parent 09501466 Feb 2000 US
Child 10290777 US
Continuation in Parts (1)
Number Date Country
Parent 11020936 Dec 2004 US
Child 11726074 US